Seegene Medical Foundation Wins Top Medical Services Award at NYF K-NBA

Dong-A Ilbo is proud to report that the Seegene Medical Foundation has achieved a significant international accolade, securing the top position in the medical services category at the prestigious '2026 NYF K-NBA' awards. This recognition is not merely for diagnostic capabilities but for our innovative 'integrated overseas medical model,' which seamlessly links diagnosis, treatment, and post-care management.

“

The award recognizes Seegene's integrated overseas medical model, which connects diagnosis, treatment, and follow-up care.

Our success is underscored by the establishment of independent testing centers in key international locations, including Los Angeles, USA; Almaty, Kazakhstan; and Hanoi, Vietnam. These centers offer a comprehensive service, extending beyond business-to-business diagnostics to include direct-to-consumer self-testing, executive check-ups, patient treatment referrals, and pre- and post-care services. This full-service approach effectively addresses gaps in local healthcare infrastructure, setting us apart from simple export-oriented diagnostic services.

Furthermore, the induction of Chairman Chun Jong-ki into the 'NYF Hall of Fame' is a momentous occasion, highlighting his long-term contributions to brand value enhancement. Such an honor for a South Korean medical professional is exceptionally rare and speaks volumes about his leadership and vision. Our technological prowess, particularly in standardizing test data and employing AI analysis through systems like CURECA and SeeLIS, ensures consistent quality across our global operations. This commitment to quality infrastructure is the bedrock of our international expansion.

“

The Hall of Fame is a special honor given to individuals who have contributed to enhancing brand value in the long term.

This achievement at the NYF K-NBA, an event organized by the New York Festivals, one of the world's top three advertising festivals, validates our efforts to elevate the national brand through excellence in healthcare. It demonstrates that South Korean innovation and dedication in the medical field are not only competitive but leading on the global stage.

“

We have established systems such as the CURECA automated PCR testing process, the next-generation test information system SeeLIS, and the AI-based pathology quality management system SeeDP, laying the foundation for maintaining uniform quality of domestic and international tests.